Does anyone know what happened to the Parkinsons Glove we saw on the news?
It isn't a medication so can't they just manufacture them and let people try them?
Does anyone know what happened to the Parkinsons Glove we saw on the news?
It isn't a medication so can't they just manufacture them and let people try them?
No, they're going for FDA approval and in the process of planning the next clinical trials. They just received a patent for the gloves. There's some more info here:
pdoptimism.com/glove-buzz-t...
I wish the FDA would hurry up.
It' not the FDA who needs to hurry up at this stage. Until somone submits an application backed by trial results, there is nothing for the FDA to do.
Synergia have a trial in progress at the moment but it wont complete until next year. 2 out of 2 of its participants on this forum reported they did better on the placebo. If Synergia complete the trial, and its results are positive, and the FDA approve it, they potentially face patent protection legal action by Stanford
Stanford haven't even started recruiting for their pre-FDA approval "proof of concept" trials yet, and don't plan to start FDA approval trials until the "proof of concepts" are complete
If glove testing establishes the gloves work, (not by any means a "given"), and if Synergia can negotiate a suitable royalty agreement with Stanford (another "not given") then maybe approved medical use gloves will be commercially available before the end of 2024
If not, again - if Stanford can prove the gloves work, then its hard to see a Stanford glove being commercially available before the end of 2025
But not due to waiting for the FDA
There's also some discussion in the following thread: healthunlocked.com/cure-par...
Since it is a medical device they can't sell it without FDA clearance. By doing the trials and going through the approval process they will be able to make claims (hopefully supported by the trials) about it's efficacy. And of course as a medical device they will make millions more. Hopefully its simplicity will help keep the price down.